Document Detail

Effect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure.
MedLine Citation:
PMID:  21029826     Owner:  NLM     Status:  MEDLINE    
The beneficial effects of spironolactone in chronic heart failure (HF) have been demonstrated in patients with New York Heart Association (NYHA) class III to IV HF. This study examined the effect of spironolactone on left ventricular (LV) function and functional capacity of patients with mild to moderate HF (NYHA class I to II). One hundred sixty-eight patients with NYHA class I to II HF and LV ejection fraction ≤40% were randomized to spironolactone or placebo and assessed by echocardiography, gated single-photon emission computed tomography, technetium-99m sestamibi single-photon emission computed tomographic radionuclide ventriculography, and cardiopulmonary exercise testing at baseline and after 6 months of treatment. In the spironolactone group LV ejection fraction increased from 35.2 ± 0.7% to 39.1 ± 3.5% (p <0.001), with a decrease in LV end-diastolic and end-systolic volumes and myocardial mass and an improvement in LV diastolic filling pattern. Cardiopulmonary exercise testing parameters did not change. In conclusion, administration of spironolactone to patients with NYHA class I to II HF has beneficial effects on LV remodeling and diastolic function.
Enrico Vizzardi; Antonio D'Aloia; Raffaele Giubbini; Tania Bordonali; Silvia Bugatti; Natalia Pezzali; Alessia Romeo; Alessandra Dei Cas; Marco Metra; Livio Dei Cas
Related Documents :
12231086 - Echocardiographic determinants of mitral early flow propagation velocity.
9068516 - Prognostic importance of scintigraphic left ventricular cavity dilation during intraven...
18558476 - Evaluation of right intraventricular dyssynchrony by two-dimensional strain echocardiog...
11374766 - Novel device to change left ventricular shape for heart failure treatment: device desig...
12778026 - Acute reductions in ventricular myocardial tissue velocities after direct current cardi...
16751676 - Safety of percutaneous left heart catheterization directly performed by cardiology fell...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial     Date:  2010-09-09
Journal Detail:
Title:  The American journal of cardiology     Volume:  106     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2010-12-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1292-6     Citation Subset:  AIM; IM    
Copyright Information:
Copyright © 2010 Elsevier Inc. All rights reserved.
Department of Cardiology, University of Brescia, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone Antagonists / therapeutic use*
Analysis of Variance
Biological Markers / blood
Echocardiography, Doppler
Exercise Test
Heart Failure / drug therapy*,  physiopathology,  radionuclide imaging,  ultrasonography
Middle Aged
Oxygen Consumption / physiology
Radiopharmaceuticals / diagnostic use
Single-Blind Method
Spironolactone / therapeutic use*
Stroke Volume / drug effects*
Technetium Tc 99m Sestamibi / diagnostic use
Tomography, Emission-Computed, Single-Photon
Treatment Outcome
Reg. No./Substance:
0/Aldosterone Antagonists; 0/Biological Markers; 0/Placebos; 0/Radiopharmaceuticals; 109581-73-9/Technetium Tc 99m Sestamibi; 52-01-7/Spironolactone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patient...
Next Document:  Effect of renal function on survival after implantable cardioverter defibrillator placement.